Dan Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dan Wang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Jun-Xia Zhai
Department of Novelty Retrieval, Institute of Hebei Medical Information, Shijiazhuang 050071, Hebei Province, China
9 shared publications - Dian-Wu Liu
Department of Epidemiology and Biostatistics, School of Public Health, Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
8 shared publications Bin Wang
Department of Rheumatology and Immunology, Jinshan Hospital of Fudan University, Shanghai 201508, China; Department of Endocrinology, Jinshan Hospital of Fudan University, Shanghai 201508, China
4 shared publicationsAijun Li
Department of Graduates Management Brigade, The Second Military Medical University, Shanghai 200433, China
2 shared publicationsDeqiang Zhang
State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai 200433, China
2 shared publicationsGang Huang
The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China
2 shared publications
Latest Publications
- 9 May 2023
- Published by Emerald Publishing in Library Hi Tech
- Vol. 42 (5) , 1601-1633
Bibliometric analyses and network mapping on the smart library in Web of Science from 2003 to 2021
Purpose: This research conducts bibliometric analyses and network mapping on smart libraries worldwide. It examines publication profiles, identifies the most cited publications and preferred sources and considers the cooperation of the authors, organizations and countries worldwide. The research also highlights keyword trends and clusters and finds new developments and emerging trends from the co-cited references network.Design/methodology/approach: A total of 264 records with 1,200 citations were extracted from the Web of Science database from 2003 to 2021. The trends in the smart library were analyzed and visualized using BibExcel, VOSviewer, Biblioshiny and CiteSpace.Findings: The People’s Republic of China had the most publications (119), the most citations (374), the highest H-index (12) and the highest total link strength (TLS = 25). Wuhan University had the highest H-index (6). Chiu, Dickson K. W. (H-index = 4, TLS = 22) and Lo, Patrick (H-index = 4, TLS = 21) from the University of Hong Kong had the highest H-indices and were the most cooperative authors. Library Hi Tech was the most preferred journal. “Mobile library” was the most frequently used keyword. “Mobile context” was the largest cluster on the research front.Research limitations/implications: This study helps librarians, scientists and funders understand smart library trends.Originality/value: There are several studies and solid background research on smart libraries. However, to the best of the author’s knowledge, this study is the first to conduct bibliometric analyses and network mapping on smart libraries around the globe.
- 9 May 2023
- Published by Emerald Publishing in Library Hi Tech
- Vol. 42 (5) , 1601-1633
Bibliometric analyses and network mapping on the smart library in Web of Science from 2003 to 2021
Purpose: This research conducts bibliometric analyses and network mapping on smart libraries worldwide. It examines publication profiles, identifies the most cited publications and preferred sources and considers the cooperation of the authors, organizations and countries worldwide. The research also highlights keyword trends and clusters and finds new developments and emerging trends from the co-cited references network.Design/methodology/approach: A total of 264 records with 1,200 citations were extracted from the Web of Science database from 2003 to 2021. The trends in the smart library were analyzed and visualized using BibExcel, VOSviewer, Biblioshiny and CiteSpace.Findings: The People’s Republic of China had the most publications (119), the most citations (374), the highest H-index (12) and the highest total link strength (TLS = 25). Wuhan University had the highest H-index (6). Chiu, Dickson K. W. (H-index = 4, TLS = 22) and Lo, Patrick (H-index = 4, TLS = 21) from the University of Hong Kong had the highest H-indices and were the most cooperative authors. Library Hi Tech was the most preferred journal. “Mobile library” was the most frequently used keyword. “Mobile context” was the largest cluster on the research front.Research limitations/implications: This study helps librarians, scientists and funders understand smart library trends.Originality/value: There are several studies and solid background research on smart libraries. However, to the best of the author’s knowledge, this study is the first to conduct bibliometric analyses and network mapping on smart libraries around the globe.
- 1 April 2023
- Published by Bentham Science Publishers Ltd. in Combinatorial Chemistry & High Throughput Screening
- Vol. 26 (5) , 906-915
Comparison of Serum Folate between Schizophrenic Patients and Healthy Controls in Chinese Han Adult Population: A Systematic Review and Meta-Analysis
Aim and Objective: To assess the relationship between serum folate and schizophrenia (SZ) risk in the Chinese Han adult population in different papers, a systematic review and metaanalysis were conducted. Materials and Methods: We searched for this meta-analysis on three English databases (PubMed, Embase, and Web of science) and four Chinese databases (CNKI, SinoMed, Wanfang, and CQVIP) on March 27, 2021. Inclusion criteria: studies provided folate levels in serum of cases and controls as mean and standard deviation. Exclusion criteria: subjects were not Chinese Han adult population. The Newcastle-Ottawa Scale score was used to assess the risk of bias in the included studies. Standard mean difference (SMD) was used to measure the difference between SZ patients and healthy controls. Subgroup analyses by measurement time, duration, and age were performed, respectively. Results: This meta-analysis included 19 publications involving 1571 SZ cases and 1283 healthy controls. In total studies, the pooled result showed that SZ patients had decreased serum folate levels compared with healthy controls (SMD [95%CI] = -1.37[-1.83,-0.90], PSMD<0.001), and in most of the subgroups, the associations reached decreased significantly; while in the subgroup of drugs use, the association was not reached significantly. Conclusion: Dose-response analysis and subgroup analyses by gender were not performed due to the lack of data. Folate deficiency is associated with the patients, and antipsychotic drugs might have positive effects on improving serum folate levels in Chinese Han adult SZ.
- 1 April 2023
- Published by Bentham Science Publishers Ltd. in Combinatorial Chemistry & High Throughput Screening
- Vol. 26 (5) , 906-915
Comparison of Serum Folate between Schizophrenic Patients and Healthy Controls in Chinese Han Adult Population: A Systematic Review and Meta-Analysis
Aim and Objective: To assess the relationship between serum folate and schizophrenia (SZ) risk in the Chinese Han adult population in different papers, a systematic review and metaanalysis were conducted. Materials and Methods: We searched for this meta-analysis on three English databases (PubMed, Embase, and Web of science) and four Chinese databases (CNKI, SinoMed, Wanfang, and CQVIP) on March 27, 2021. Inclusion criteria: studies provided folate levels in serum of cases and controls as mean and standard deviation. Exclusion criteria: subjects were not Chinese Han adult population. The Newcastle-Ottawa Scale score was used to assess the risk of bias in the included studies. Standard mean difference (SMD) was used to measure the difference between SZ patients and healthy controls. Subgroup analyses by measurement time, duration, and age were performed, respectively. Results: This meta-analysis included 19 publications involving 1571 SZ cases and 1283 healthy controls. In total studies, the pooled result showed that SZ patients had decreased serum folate levels compared with healthy controls (SMD [95%CI] = -1.37[-1.83,-0.90], PSMD<0.001), and in most of the subgroups, the associations reached decreased significantly; while in the subgroup of drugs use, the association was not reached significantly. Conclusion: Dose-response analysis and subgroup analyses by gender were not performed due to the lack of data. Folate deficiency is associated with the patients, and antipsychotic drugs might have positive effects on improving serum folate levels in Chinese Han adult SZ.
- 1 July 2017
- Published by Elsevier in Autoimmunity Reviews
- Vol. 16 (7) , 756-765
Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis
- 1 July 2017
- Published by Elsevier in Autoimmunity Reviews
- Vol. 16 (7) , 756-765
Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis
- 1 March 2017
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 443 (C) , 72-79
Serum folate, vitamin B12 levels and diabetic peripheral neuropathy in type 2 diabetes: A meta-analysis
- 1 March 2017
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 443 (C) , 72-79
Serum folate, vitamin B12 levels and diabetic peripheral neuropathy in type 2 diabetes: A meta-analysis
- 1 February 2016
- Published by Taylor & Francis in Neurological Research
- Vol. 38 (2) , 144-150
Glutathione S-transferase M1 polymorphisms and Parkinson’s disease risk: a meta-analysis
Objectives: Studies examining whether glutathione S-transferase M1 (GSTM1) polymorphisms are associated with Parkinson’s disease (PD) have reported inconsistent results. To clarify those inconsistencies, a meta-analysis was performed. Methods: The electronic databases were searched for all publications regarding the association. Studies were included if they met the eligibility criteria. The strength of the association between GSTM1 polymorphisms and PD risk was measured by odds ratios (ORs) and 95% confidence intervals (CIs) in the recessive genetic model (null genotype vs. present genotype). Subgroup analyses by ethnicity and OR type were performed. Results: A total of 22 publications (23 studies) were included. There were 14, 7 and 2 studies with Caucasians, Asians and Latinos, respectively. OR types were 15 and 8 studies with crude and adjusted ORs, respectively. The combined results of the overall analysis showed that the GSTM1 null genotype was not significantly associated with PD risk (ORrandom-effects = 1.06, 95% CI = 0.95–1.19). In subgroup analyses by ethnicity, no significant associations were found in Caucasians, Asians or Latinos individually. Similarly, there were no associations in the subgroup analyses by OR type. There were no obvious publication biases in any of the comparisons. Discussion: The results of this meta-analysis suggest that the GSTM1 null genotype is not significantly associated with PD risk.
- 1 February 2016
- Published by Taylor & Francis in Neurological Research
- Vol. 38 (2) , 144-150
Glutathione S-transferase M1 polymorphisms and Parkinson’s disease risk: a meta-analysis
Objectives: Studies examining whether glutathione S-transferase M1 (GSTM1) polymorphisms are associated with Parkinson’s disease (PD) have reported inconsistent results. To clarify those inconsistencies, a meta-analysis was performed. Methods: The electronic databases were searched for all publications regarding the association. Studies were included if they met the eligibility criteria. The strength of the association between GSTM1 polymorphisms and PD risk was measured by odds ratios (ORs) and 95% confidence intervals (CIs) in the recessive genetic model (null genotype vs. present genotype). Subgroup analyses by ethnicity and OR type were performed. Results: A total of 22 publications (23 studies) were included. There were 14, 7 and 2 studies with Caucasians, Asians and Latinos, respectively. OR types were 15 and 8 studies with crude and adjusted ORs, respectively. The combined results of the overall analysis showed that the GSTM1 null genotype was not significantly associated with PD risk (ORrandom-effects = 1.06, 95% CI = 0.95–1.19). In subgroup analyses by ethnicity, no significant associations were found in Caucasians, Asians or Latinos individually. Similarly, there were no associations in the subgroup analyses by OR type. There were no obvious publication biases in any of the comparisons. Discussion: The results of this meta-analysis suggest that the GSTM1 null genotype is not significantly associated with PD risk.
- 1 January 2016
- Published by Elsevier in Psychiatry Research
- Vol. 235, 83-89
Serum folate levels in schizophrenia: A meta-analysis
- 1 January 2016
- Published by Elsevier in Psychiatry Research
- Vol. 235, 83-89
Serum folate levels in schizophrenia: A meta-analysis
- Open Access
- 1 January 2015
- Published by Genetics and Molecular Research in Genetics and Molecular Research
- Vol. 14 (1) , 79-88
Anticancer activity of Bombyx batryticatus ethanol extract against the human tumor cell line HeLa
Anticancer activity of Bombyx batryticatus ethanol extract (BBE) against HeLa cells was studied using cell viability, DNA fragmentation, real-time polymerase chain reaction, and Western blot analyses. The BBE inhibited the growth and induced apoptosis of HeLa cells. The MTT assay indicated that the BBE induced cytotoxicity in HeLa cells in a time- and concentration-dependent manner. When HeLa cells were treated for 48 h, the 50% inhibitory concentration (IC₅₀) value for the BBE was 1.564 mg/mL. The microscopy results showed that HeLa cells were severely distorted and showed slow growth; some cells became round in shape when treated with 5 mg/mL BBE for 24 h. The DNA ladder results revealed excessive DNA fragmentation in HeLa cells treated with 7 mg/mL BBE for 36 h. The proapoptotic activity of the BBE was attributed to its ability to modulate the expression of Bcl-2 and Bax genes. The mRNA and protein expression levels of Bax were remarkably higher whereas those of Bcl-2 were lower than those in the control cells; this led to an increased Bax/Bcl-2 ratio in cells treated with the BBE for 36 h. The results suggest that the BBE might play an important role in tumor growth suppression by inducing apoptosis in human cervical cancer cells via the regulation of the Bcl-2- and Bax-mediated apoptotic pathways.
- 1 January 2015
- Published by Genetics and Molecular Research in Genetics and Molecular Research
- Vol. 14 (1) , 79-88
Open AccessAnticancer activity of Bombyx batryticatus ethanol extract against the human tumor cell line HeLa
Anticancer activity of Bombyx batryticatus ethanol extract (BBE) against HeLa cells was studied using cell viability, DNA fragmentation, real-time polymerase chain reaction, and Western blot analyses. The BBE inhibited the growth and induced apoptosis of HeLa cells. The MTT assay indicated that the BBE induced cytotoxicity in HeLa cells in a time- and concentration-dependent manner. When HeLa cells were treated for 48 h, the 50% inhibitory concentration (IC₅₀) value for the BBE was 1.564 mg/mL. The microscopy results showed that HeLa cells were severely distorted and showed slow growth; some cells became round in shape when treated with 5 mg/mL BBE for 24 h. The DNA ladder results revealed excessive DNA fragmentation in HeLa cells treated with 7 mg/mL BBE for 36 h. The proapoptotic activity of the BBE was attributed to its ability to modulate the expression of Bcl-2 and Bax genes. The mRNA and protein expression levels of Bax were remarkably higher whereas those of Bcl-2 were lower than those in the control cells; this led to an increased Bax/Bcl-2 ratio in cells treated with the BBE for 36 h. The results suggest that the BBE might play an important role in tumor growth suppression by inducing apoptosis in human cervical cancer cells via the regulation of the Bcl-2- and Bax-mediated apoptotic pathways.
- 3 August 2014
- Published by Springer Nature in Molecular Biology Reports
- Vol. 41 (11) , 7423-7430
Null genotype of GSTT1 contributes to increased Parkinson’s disease risk in Caucasians: evidence from a meta-analysis
Conflicting results in previous case–control studies on the association between Glutathione S-transferase T1 (GSTT1) gene polymorphism and Parkinson’s disease (PD) risk have been reported, so we conducted this meta-analysis. We searched and extracted data from 3 Chinese and 3 English web-based electronic databases to evaluate the associations by odds ratio (OR) and its 95 % confidence interval (CI) under the recessive genetic comparison model (null genotype vs. present genotype). We also conducted subgroup analyses by ethnicity and adjusted status of OR, respectively. Meta-analyses and subgroup analyses of larger studies (sample size ≥300) were also reanalyzed. When 18 eligible studies (3,963 PD cases and 5,472 controls) were pooled to analyze the association, we found no statistically significant result (OR 1.24, 95 % CI 0.96–1.60). In the subgroup analyses by ethnicity, there was statistically significant association between the null genotype of GSTT1 and PD risk among Caucasians, while the associations were not found among Asians and Latinos. In the subgroup analyses by adjusted status of OR, there were no significant associations both in studies with crude OR and adjusted OR. Meta-analyses and subgroup analyses of larger studies (sample size ≥300) were also confirmed the associations mentioned above. Power analysis indicated only meta-analysis of Caucasians had enough evidence to claim the association. In conclusion, the meta-analysis suggests that the null genotype of GSTT1 contributes to PD risk in Caucasians, and no association in Asians is needed more studies to confirm.
- 3 August 2014
- Published by Springer Nature in Molecular Biology Reports
- Vol. 41 (11) , 7423-7430
Null genotype of GSTT1 contributes to increased Parkinson’s disease risk in Caucasians: evidence from a meta-analysis
Conflicting results in previous case–control studies on the association between Glutathione S-transferase T1 (GSTT1) gene polymorphism and Parkinson’s disease (PD) risk have been reported, so we conducted this meta-analysis. We searched and extracted data from 3 Chinese and 3 English web-based electronic databases to evaluate the associations by odds ratio (OR) and its 95 % confidence interval (CI) under the recessive genetic comparison model (null genotype vs. present genotype). We also conducted subgroup analyses by ethnicity and adjusted status of OR, respectively. Meta-analyses and subgroup analyses of larger studies (sample size ≥300) were also reanalyzed. When 18 eligible studies (3,963 PD cases and 5,472 controls) were pooled to analyze the association, we found no statistically significant result (OR 1.24, 95 % CI 0.96–1.60). In the subgroup analyses by ethnicity, there was statistically significant association between the null genotype of GSTT1 and PD risk among Caucasians, while the associations were not found among Asians and Latinos. In the subgroup analyses by adjusted status of OR, there were no significant associations both in studies with crude OR and adjusted OR. Meta-analyses and subgroup analyses of larger studies (sample size ≥300) were also confirmed the associations mentioned above. Power analysis indicated only meta-analysis of Caucasians had enough evidence to claim the association. In conclusion, the meta-analysis suggests that the null genotype of GSTT1 contributes to PD risk in Caucasians, and no association in Asians is needed more studies to confirm.
- 27 June 2013
- Published by Springer Nature in Tumor Biology
- Vol. 34 (6) , 3509-3517
Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies
There were some case–control studies, nested case–control studies, and cohort studies with controversial results on the association between serum 25-hydroxyvitamin D [25(OH)D] and breast cancer risk. Case–control studies are prone to selection bias, which limit the strength and quality of the evidence. To overcome the shortcoming of the case–control studies, the meta-analysis of prospective studies including nested case–control studies and cohort studies was conducted. PubMed, Embase, and Web of Science databases were searched, and the last retrieval date was March 24, 2013. For the highest versus the lowest level of serum 25(OH)D, the relative risks (RRs) and its 95 % confidence intervals (CIs) from each study were used to estimate summary RR and its 95 % CI. Subgroup analyses by geographic region, menopausal status, and adjusted status of RR were also performed, respectively. A dose–response association between serum 25(OH)D concentration and breast cancer risk was assessed. Fourteen articles with 9,110 breast cancer cases and 16,244 controls were included in the meta-analysis. Overall, serum 25(OH)D levels were inversely significantly associated with breast cancer risk (RR = 0.845, 95 % CI = 0.750–0.951). Inversely statistically significant associations were observed in North American studies, postmenopausal women, and studies with adjusted and unadjusted RR, respectively. No statistically significant associations were observed in European studies and premenopausal women, respectively. Dose–response analysis showed that every 10 ng/mL increment in serum 25(OH)D concentration was associated with a significant 3.2 % reduction in breast cancer risk. This meta-analysis provides evidence of a significantly inverse association between serum 25(OH)D concentration and breast cancer risk.
- 27 June 2013
- Published by Springer Nature in Tumor Biology
- Vol. 34 (6) , 3509-3517
Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies
There were some case–control studies, nested case–control studies, and cohort studies with controversial results on the association between serum 25-hydroxyvitamin D [25(OH)D] and breast cancer risk. Case–control studies are prone to selection bias, which limit the strength and quality of the evidence. To overcome the shortcoming of the case–control studies, the meta-analysis of prospective studies including nested case–control studies and cohort studies was conducted. PubMed, Embase, and Web of Science databases were searched, and the last retrieval date was March 24, 2013. For the highest versus the lowest level of serum 25(OH)D, the relative risks (RRs) and its 95 % confidence intervals (CIs) from each study were used to estimate summary RR and its 95 % CI. Subgroup analyses by geographic region, menopausal status, and adjusted status of RR were also performed, respectively. A dose–response association between serum 25(OH)D concentration and breast cancer risk was assessed. Fourteen articles with 9,110 breast cancer cases and 16,244 controls were included in the meta-analysis. Overall, serum 25(OH)D levels were inversely significantly associated with breast cancer risk (RR = 0.845, 95 % CI = 0.750–0.951). Inversely statistically significant associations were observed in North American studies, postmenopausal women, and studies with adjusted and unadjusted RR, respectively. No statistically significant associations were observed in European studies and premenopausal women, respectively. Dose–response analysis showed that every 10 ng/mL increment in serum 25(OH)D concentration was associated with a significant 3.2 % reduction in breast cancer risk. This meta-analysis provides evidence of a significantly inverse association between serum 25(OH)D concentration and breast cancer risk.
- Open Access
- 20 July 2012
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 6 (4) , 797-804
Association between manganese superoxide dismutase gene polymorphism and breast cancer risk: A meta-analysis of 17,842 subjects
The aim of this meta-analysis was to explore the association between the manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk, and to investigate the interaction of this gene polymorphism with known risk factors for breast cancer. Crude odds ratios (ORs) with 95% confidence intervals (CIs) for breast cancer risk associated with co-dominant models [valine/alanine (Val/Ala) vs. Val/Val, Ala/Ala vs. Val/Val], a dominant model (Val/Ala + Ala/Ala vs. Val/Val) and a recessive model (Ala/Ala vs. Val/Ala + Val/Val) were statistically estimated. This meta‑analysis included 8,102 breast cancer cases and 9,740 controls from 14 published case-control studies. The data revealed no significant association between the MnSOD polymorphism and the risk of developing breast cancer. However, upon subgroup analyses, the risk was significantly increased in premenopausal women with the dominant model of the MnSOD gene polymorphism (OR, 1.15; 95% CI, 1.01-1.31). Statistically significant increased risks were also identified in women with the MnSOD genotypes containing the Ala allele who had a tobacco smoking history (OR, 1.17; 95% CI, 1.02-1.34), a higher body mass index (OR, 1.26; 95% CI, 1.02-1.56) or who used oral contraceptives (OR, 1.98; 95% CI, 1.34-2.93). By contrast, there was no significant association between breast cancer risk and alcohol consumption and ethnicity. This meta‑analysis demonstrated no statistically significant association between the MnSOD gene polymorphism and breast cancer susceptibility, except in premenopausal women with certain unhealthy lifestyle habbits.
- 20 July 2012
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 6 (4) , 797-804
Open AccessAssociation between manganese superoxide dismutase gene polymorphism and breast cancer risk: A meta-analysis of 17,842 subjects
The aim of this meta-analysis was to explore the association between the manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk, and to investigate the interaction of this gene polymorphism with known risk factors for breast cancer. Crude odds ratios (ORs) with 95% confidence intervals (CIs) for breast cancer risk associated with co-dominant models [valine/alanine (Val/Ala) vs. Val/Val, Ala/Ala vs. Val/Val], a dominant model (Val/Ala + Ala/Ala vs. Val/Val) and a recessive model (Ala/Ala vs. Val/Ala + Val/Val) were statistically estimated. This meta‑analysis included 8,102 breast cancer cases and 9,740 controls from 14 published case-control studies. The data revealed no significant association between the MnSOD polymorphism and the risk of developing breast cancer. However, upon subgroup analyses, the risk was significantly increased in premenopausal women with the dominant model of the MnSOD gene polymorphism (OR, 1.15; 95% CI, 1.01-1.31). Statistically significant increased risks were also identified in women with the MnSOD genotypes containing the Ala allele who had a tobacco smoking history (OR, 1.17; 95% CI, 1.02-1.34), a higher body mass index (OR, 1.26; 95% CI, 1.02-1.56) or who used oral contraceptives (OR, 1.98; 95% CI, 1.34-2.93). By contrast, there was no significant association between breast cancer risk and alcohol consumption and ethnicity. This meta‑analysis demonstrated no statistically significant association between the MnSOD gene polymorphism and breast cancer susceptibility, except in premenopausal women with certain unhealthy lifestyle habbits.